References
- Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26:809–815.
- Repasky E, Eng J, Hylander B. Stress, metabolism and cancer: integrated pathways contributing to immune suppression. J Cancer Educ. 2015;21(2):97–103.
- Christopher T, Gradishar W, O'Shaughnessy J, Bramsen B, Lurie R. Clinical roundtable monograph: effective management of quality of life in metastatic breast cancer. Clin Adv Hematol Oncol. 2014;12(Suppl 4):1–14.
- Eng J, Kokolus K, Reed C, Hylander B, Ma W, Repasky E. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response. Cancer Immunol Immunother. 2014;63:1115–1128.
- Lehart I, Metsios G, Nevill A, Carmichael A. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54:635–654.
- Marinac C, Nelson S, Breen C, et al. Prolonged nightly fasting and breast cancer prognosis. JAMA Oncol. 2016;2:1049–1055.
- Global status of advanced/metastatic breast cancer: 2005–2015 decade report. Available online at: breastcancervision.com/sites/default/files/Decade%20Report_Full%20Report_Final.pdf. Last accessed November 1, 2017.
- Danesh M, Belkora J, Volz S, Rugo HS. Informational needs of patients with metastatic breast cancer: what questions do they ask, and are physicians answering them? J Cancer Educ. 2014;29:175–180.